Skip to main content
Canna~Fangled Abstracts

Examining the role of cannabinoids on osteoporosis: a review

By November 19, 2022November 22nd, 2022No Comments

Review
. 2022 Nov 19;17(1):146.

doi: 10.1007/s11657-022-01190-x.

Grace Clouse 1, Samantha Penman 1, Michael Hadjiargyrou 2, David E Komatsu 3, Panayotis K Thanos 4 5
Affiliations 

Abstract

Purpose: Prior research studies have shown that the endocannabinoid system, influenced by CBD and THC, plays a role in bone remodeling. As both the research on cannabis and use of cannabis continue to grow, novel medicinal uses of both its constituents as well as the whole plant are being discovered. This review examines the role of cannabinoids on osteoporosis, more specifically, the endocannabinoid system and its role in bone remodeling and the involvement of the cannabinoid receptors 1 and 2 in bone health, as well as the effects of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and synthetic cannabinoids on bone.

Methods: A comprehensive literature search of online databases including PUBMED was utilized.

Results: A total of 29 studies investigating the effects of cannabis and/or its constituents as well as the activation or inactivation of cannabinoid receptors 1 and 2 were included and discussed.

Conclusion: While many of the mechanisms are still not yet fully understood, both preclinical and clinical studies show that the effects of cannabis mediated through the endocannabinoid system may prove to be an effective treatment option for individuals with osteoporosis.

Keywords: Bone, Cannabidiol (CBD), Cannabinoids, Cannabis, Osteoporosis, Δ9-Tetrahydrocannabinol (THC)

References

    1. Pain S (2015) A potted history. Nature 525:S10-11 – PubMed
    1. Ebbert JO, Scharf EL, Hurt RT (2018) Medical cannabis. Mayo Clin Proc 93:1842–1847 – PubMed
    1. Amin MR, Ali DW (2019) Pharmacology of medical cannabis. Adv Exp Med Biol 1162:151–165 – PubMed
    1. Belendiuk KA, Baldini LL, Bonn-Miller MO (2015) Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract 10:10 – PubMed – PMC
    1. Chayasirisobhon S (2019) Cannabis and neuropsychiatric disorders: an updated review. Acta Neurol Taiwan 28(2):27–39 – PubMed

Publication types

MeSH terms

Substances

LinkOut – more resources

Leave a Reply